Alkanols (or 1-alcohols) are small volatile aliphatic compounds that partition rapidly across the plasma membrane and have the potential to induce anesthesia at high doses[@b1]. Alkanols have been shown to target both cytoplasmic and plasma membrane proteins[@b2][@b3], including voltage-gated K^+^ (K~v~) channels[@b4]. K~v~ channels play an important role in cellular excitability as they constitute the cell's repolarizing power; they shape the action potential duration and help setting the threshold for initiating one.

K~v~ channels are assembled from four α-subunits, each containing six transmembrane segments (S1--S6) whereby the S5--S6 segments create the K^+^ pore[@b5]. K^+^ flow through this pore is controlled by a channel gate that is located in the lower carboxyl-terminal part of S6 (S6~c~)[@b6]. Via an electromechanical coupling, composed of the S4--S5 linker and S6~c~, opening and closure of the channel gate is controlled by the four voltage-sensing domains (VSD) that consist of the S1--S4 segments. Upon changes in the membrane potential, the positively charged residues on the S4 segment (gating charges) move across the plasma membrane generating a transient 'gating current' (I~G~)[@b7][@b8]. In the generally accepted gating scheme for *Shaker*-type K~v~ channels, the four VSDs move in a largely independent way from their inward facing rested state to their outward facing activated configuration[@b9][@b10][@b11]. This transition(s) carries approximately 90% of the total gating charge but does not open the channel gate. Once all four VSDs have reached their activated state, channel gate opening proceeds in a subunit-concerted manner which is accompanied by moving the last 10% of the gating charge[@b12][@b13][@b14]. Furthermore, channel gate opening stabilizes the VSD in its outward facing activated state and is manifested in slower VSD deactivation kinetics[@b10][@b15].

Analyzing the sensitivity of different K~v~ channels to alkanols revealed an inter-species difference wherein the K~v~ channels from the fruit fly *drosophila melanogaster* displayed a higher affinity than their mammalian orthologs[@b16][@b17]. The higher alkanol sensitivity of the *drosophila Shaw*2 channel could be transplanted onto its mammalian K~v~3.4 counterpart by exchanging the S4--S5 linker[@b18]. Site-specific residue substitution studies further supported that the S4--S5 linker forms with possible contribution of S6~c~ a key determinant in channel inhibition by alkanols[@b4][@b19][@b20][@b21][@b22]. To elucidate alkanols' mechanism of action, we performed detailed gating current analysis of the *drosophila Shaker* K~v~ channel and show that 1-Butanol (1-BuOH) and 1-Hexanol (1-HeOH) stabilize the channel in the non-conducting activated state, which results in a 10% reduction in gating charge movement and an accelerated VSD deactivation. Although this behavior was reminiscent to the effect of 4-aminopyridine (4-AP)[@b14][@b23], alkanols act via a distinct binding site for preventing the *Shaker* K~v~ channel of passing the final subunit-concerted transition leading to channel opening.

Results
=======

Concentration-dependent inhibition of Shaker K~v~ channel by 1-BuOH and 1-HeOH
------------------------------------------------------------------------------

The *drosophila Shaw2 *K~v~ channel was identified to display the highest sensitivity for alkanols and has therefore been the subject to study the mechanism of their action[@b4][@b16][@b19][@b21]. The *drosophila Shaker* K~v~ channel was also inhibited by alkanols but compared to *Shaw2* it displayed a lower sensitivity[@b17]. Since its cloning, the *Shaker* K~v~ channel became rapidly the prototypical K~v~ channel for structure-function studies and most of the current knowledge on the operation of the VSDs, the electromechanical coupling and the channel gate is based on studies in this channel. Thus, despite its lower sensitivity, the available knowledge on the gating mechanism is an advantage of the *Shaker* K~v~ channel for determining the mechanism of channel inhibition by alkanols.

Alkanols are classified in short chain (up to 5 carbonyls, C1 to C5) or long chain (C6 -- C22) 1-alcohols[@b24]. In this study, 1-BuOH and 1-HeOH were chosen as representative compounds of a short and long chain alkanol. Their effect was tested on both the ionic (I~K~) and gating (I~G~) currents of the fast (N-type) inactivation removed *Shaker*-IR channel. At the I~K~ level, *Shaker-*IR was inhibited by both 1-BuOH and 1-HeOH in a concentration-dependent manner ([Fig. 1A--C](#f1){ref-type="fig"}). For 1-BuOH a concentration-response curve was obtained with an IC~50~ value of 51.8 ± 5.9 mM (*n* = 5) and a Hill coefficient of 0.92 ± 0.04 ([Fig. 1D](#f1){ref-type="fig"}). 1-HeOH had a slightly higher affinity and yielded a concentration-response curve with an IC~50~ value of 2.7 ± 0.2 mM (*n* = 7) and a Hill coefficient of 1.13 ± 0.22 ([Fig. 1D](#f1){ref-type="fig"}). Monitoring the development of I~K~ inhibition and analyzing the remaining steady-state I~K~ amplitude upon application of 50 mM 1-BuOH or 3 mM 1-HeOH (IC~50~ concentrations) indicated that: (1) the I~K~ inhibition developed rapidly and was fully reversible upon wash-out of both alkanols, and (2) both alkanols did not induce major alterations in the voltage dependence of channel opening nor the time constants of channel activation (τI~Kac~) and deactivation (τI~Kdeac~) ([Fig. 2](#f2){ref-type="fig"} and [Table 1](#t1){ref-type="table"}). An apparent channel inactivation behavior or rising phase in the deactivating (I~Kdeac~) tail current (i.e. a hooked tail), which are typical hallmarks for an open channel blocker, were not observed ([Fig. 1A--C](#f1){ref-type="fig"}). Thus, 1-BuOH and 1-HeOH inhibited the I~K~ amplitude without affecting the kinetics, and both compounds achieved this through a mechanism most likely different from open channel block, as proposed previously[@b4].

1-BuOH and 1-HeOH accelerate VSD deactivation and immobilize approximately 10% of the gating charge
---------------------------------------------------------------------------------------------------

The I~K~ measurements only report on the final opening of the channel gate, which is an end state in the activation pathway from closed to open. From I~G~ analysis it has been reported that the VSD traverses at least one non-conducting activated state before the channel gate opens. Channel gate opening subsequently slows down VSD deactivation[@b10][@b15], which can be visualized by gradually prolonging the duration of the depolarizing pre-pulse ([Fig. 3A](#f3){ref-type="fig"}). Thus, to assess whether 1-BuOH and 1-HeOH affect transitions early in the activation pathway, i.e. before the channel gate opened, we tested the effect of both compounds on the I~G~ recordings of the non-conducting *Shaker*-IR pore mutant W434F[@b25]. During wash-in of both 1-BuOH and 1-HeOH we noted a concentration-dependent acceleration of the deactivating (I~Gdeac~) gating currents ([Fig. 3B,C](#f3){ref-type="fig"}). Plotting the time constant of VSD deactivation (τI~Gdeac~, obtained by fitting the decaying phase of I~Gdeac~) as a function of 1-BuOH or 1-HeOH concentration yielded concentration-response curves with IC~50~ values of 67 ± 1 mM (*n* = 10) and 3.0 ± 0.4 mM (*n* = 6), and Hill coefficients of 1.3 ± 0.4 and 1.6 ± 0.3, respectively ([Fig. 3D](#f3){ref-type="fig"}).

To examine whether this acceleration in τI~Gdeac~ was associated with a reduction in gating charge movement, we integrated the activating (I~Gac~) gating currents (elicited during the depolarizing test pulse) after reaching steady-state modification of the τI~Gdeac~ kinetics. This analysis indicated that there was an alkanol-dependent reduction in gating charge movement concomitantly with the acceleration in τI~Gdeac~. The reduction in total gating charge as a function of alkanol concentration yielded for 1-BuOH and 1-HeOH concentration-response curves with IC~50~ values of 88 ± 2 mM (*n* = 10) and 13.8 ± 1.6 mM (*n* = 6), and Hill coefficients of 1.5 ± 0.2 and 1.5 ± 0.2, respectively ([Fig. 3E](#f3){ref-type="fig"}). Based on these concentration-response curves, the maximal reduction in charge movement amounted to approximately 10% and 12% upon application of 300 mM 1-BuOH and 30 mM 1-HeOH, respectively.

To determine the kinetics and voltage dependence of VSD activation, we applied incremental depolarizing voltage steps starting from a constant hyperpolarized initial voltage (activation protocol, [Fig. 4A](#f4){ref-type="fig"}). To characterize VSD deactivation adequately, a deactivation pulse protocol was used ([Fig. 4B](#f4){ref-type="fig"}). Integrating the I~Gac~ recordings, obtained in control conditions and after steady-state 1-BuOH and 1-HeOH modification, yielded charge vs. voltage QV curves ([Fig. 4C](#f4){ref-type="fig"}). Interestingly, the QV curves determined in presence of 1-BuOH or 1-HeOH displayed V~1/2~ and slope factor values similar as in control condition ([Table 1](#t1){ref-type="table"}). This indicated that neither alkanol affected the voltage dependence of the remaining gating charge movement. As noted during the wash-in protocol ([Fig. 3B,C](#f3){ref-type="fig"}), both alkanols accelerated τI~Gdeac~ without markedly altering the I~Gac~ kinetics (τI~Gac~, [Fig. 4D,E](#f4){ref-type="fig"}). Thus, both alkanols accelerated τI~Gdeac~ and immobilized approximately 10% of the gating charge movement but did not affect the voltage dependence of the early VSD movements. These observations indicated that in presence of 1-BuOH or 1-HeOH the *Shaker* channel is able to reach the non-conducting activated state but it cannot pass the subunit-cooperative step leading to channel gate opening. Accordingly, the τI~Gdeac~ values in presence of saturating alkanol concentrations should corresponded to τI~Gdeac~ in control conditions when the activating pre-pulse is very short and channels only reach the non-conducting activated state. In control conditions τI~Gdeac~ amounted at −120 mV to 0.32 ± 0.03 ms (*n* = 6) upon a brief 0.5 ms depolarization, determined from pulse protocols shown in [Fig. 3A](#f3){ref-type="fig"}. In presence of 300 mM 1-BuOH or 30 mM 1-HeOH τI~Gdeac~ at −120 mV were 0.48 ± 0.08 ms (*n* = 4) and 0.53 ± 0.10 ms (*n* = 4) respectively ([Fig. 4D,E](#f4){ref-type="fig"}), which are indeed similar to the value in control conditions.

1-alkanols and 4-AP have different binding sites but immobilize the same gating charge component
------------------------------------------------------------------------------------------------

The impact of 1-BuOH and 1-HeOH on the I~G~ recordings of the *Shaker*-IR-W434F channel was reminiscent of the effect of 4-AP that prevents the channels from passing the late subunit-cooperative step of channel gate opening, resulting in a similar 10% reduction in gating charge movement[@b14]. To assess if 4-AP and 1-BuOH immobilized the same gating charge component, we determined the reduction in gating charge movement using a mixture of 1 mM 4-AP and 300 mM 1-BuOH, which for both compounds are saturating concentrations. First, we applied 1 mM 4-AP that resulted in an approximately 10% loss of gating charge movement and an acceleration of τI~Gdeac~, as has been described before[@b14][@b23]. After establishing a steady-state 4-AP effect, we applied 300 mM 1-BuOH in the continued presence of 1 mM 4-AP. The addition of 1-BuOH did not result in an extra reduction of gating charge movement or further acceleration of the I~Gdeac~ kinetics ([Fig. 5](#f5){ref-type="fig"}). This indicated that both compounds affected the same gating charge component and further supported that alkanols stabilize the channel in the non-conducting activated state similar to 4-AP.

Although alkanols and 4-AP exert a similar effect at the gating current level, they may act through different binding sites. Whereas the binding site of 4-AP partially overlaps with that of internal pore blockers[@b26][@b27], alkanols have been proposed to target the electromechanical coupling that is located outside the K^+^ pore. To test whether 4-AP and 1-BuOH have structurally different binding sites, we performed drug competition experiments using IC~50~ concentrations of 4-AP (30 μM) and 1-BuOH (50 mM). After establishing approximately 50% steady-state I~K~ inhibition with 4-AP, we applied a mixture of 30 μM 4-AP and 50 mM 1-BuOH. This mixture resulted in 78.7 ± 4.1% (*n* = 7) inhibition of I~K~ ([Fig. 6](#f6){ref-type="fig"}), thus yielding an additional inhibition of 29% in I~K~ amplitude compared to each compound separately.

To evaluate whether 4-AP and 1-BuOH competed, the expected inhibition of the mixture was calculated using a syntopic (both compounds compete) or an allotopic (no competition) model[@b28]. Using an allotopic model and the experimentally determined inhibition of each compound separately, the predicted inhibition of the mixture was 81.4 ± 2.4% (*n* = 7). With a syntopic model the predicted inhibition was 73.4 ± 2.8% (*n* = 7). Because the experimentally determined inhibition (78.7%) differed only statistically (p \< 0.05) from the predicted value of the syntopic model ([Fig. 6](#f6){ref-type="fig"}), our data matched best an allotopic model indicating that there was no competition between both compounds.

1-BuOH and 1-HeOH activate the Shaker-IR-P475A mutant by accelerating channel opening
-------------------------------------------------------------------------------------

A previous study reported that substituting a highly conserved proline residue in the S6~c~ of the *Shaw2* channel (the second proline of a highly conserved PXP motif within the S6~c~ of K~v~ channels) by a neutral amino acid such as alanine inverted the effect of the alkanols[@b22]. Thus, instead of inhibiting the channel mutant, application of alkanols potentiated the current amplitude. An alanine substitution for the corresponding proline (P475) in *Shaker*-IR shifted the threshold for channel opening towards more depolarized potentials by affecting the late step(s) of channel gate opening while leaving earlier VSD transitions unaffected[@b29]. Consequently, the *Shaker*-IR-P475A mutant displays slow I~Kac~ kinetics that is only weakly voltage-dependent.

Applying 1-BuOH or 1-HeOH to the *Shaker*-IR-P475A mutant resulted in a concentration-dependent increase in I~K~ and an acceleration of τ I~Kac~ ([Fig. 7A,B](#f7){ref-type="fig"}), which is in agreement with previous data obtained in the *Shaw2* channel[@b22]. With higher concentrations of 1-BuOH or 1-HeOH the typical conduction versus voltage GV curves, which were determined from normalizing the deactivation tail current of activation protocols ([Fig. 8A](#f8){ref-type="fig"}), appeared to become steeper and to shift slightly towards more hyperpolarized potentials ([Fig. 8B](#f8){ref-type="fig"}, [Table 1](#t1){ref-type="table"}). However, concomitantly with the accelerated τI~Kac~ kinetics, also the inactivation process became more pronounced and the peak I~K~ amplitude started to decrease at higher alkanol concentrations ([Fig. 7A,B](#f7){ref-type="fig"}). Therefore, the small hyperpolarizing shift and steepening of the GV curves could be an apparent effect due to the accelerated channel inactivation. To test this possibility, we determined the normalized conduction G from the peak outward currents using the Goldman-Hodgkin-Katz current equation. The GV curves obtained with this approach, which should be less sensitive to inactivation, were in presence of alkanols similar to those in control conditions ([Fig. 8B](#f8){ref-type="fig"}). Thus, although both compounds resulted in I~K~ activation, neither 1-BuOH nor 1-HeOH affected the voltage dependence of channel opening substantially. To evaluate if the pronounced channel inactivation behavior reflects in fact open channel block, we examined I~Kdeac~ more closely. In contrast to what is expected with open channel block, the I~Kdeac~ recordings did not cross nor did they display a noticeable hook ([Fig. 7A,B](#f7){ref-type="fig"}). In fact, the τI~Kdeac~ kinetics accelerated markedly which suggested that also the accelerated channel inactivation was due to gating modification. All these effects were fully reversible upon wash-out of both alkanols.

The I~Kac~ of *Shaker*-IR-P475A displayed two components and was best approximated with a double exponential function yielding a fast and a slow τI~Kac~ component[@b29]. However, the fast component contributed only marginally to the overall I~K~ amplitude and the weighted τI~Kac~ kinetics approximated the value of the slow component in control condition ([Fig. 8C](#f8){ref-type="fig"}). 1-BuOH or 1-HeOH accelerated channel opening markedly but approximating the I~Kac~ currents with a double exponential function indicated that the time constants of both the fast and slow component were similar to those obtained in control condition. However, the contribution of the fast component in the total current amplitude increased as a function of alkanol concentration ([Fig. 8C](#f8){ref-type="fig"}). Consequently, the weighted τI~Kac~ accelerated with increasing alkanol concentration ([Fig. 8D,E](#f8){ref-type="fig"}). Similar to I~Kac~, the weighted τI~Kdeac~ kinetics, obtained from fitting I~Kdeac~ with a double exponential function, accelerated in an alkanol concentration-dependent manner ([Fig. 8D,E](#f8){ref-type="fig"}). Plotting the weighted τI~Kac~ as a function of 1-BuOH or 1-HeOH concentration yielded concentration-response curves with IC~50~ values of 58.8 ± 3.0 mM (*n* = 5) and 4.6 ± 0.8 mM (*n* = 4), and Hill coefficients of 1.5 ± 0.4 and 1.3 ± 0.3, respectively ([Fig. 8F](#f8){ref-type="fig"}). This indicated that the alanine substitution for P475 in S6~c~ did not affect the affinity for alkanols, suggesting that the conformation of the binding site remained intact.

1-BuOH and 1-HeOH did not affect the VSD movements of the P475A mutant
----------------------------------------------------------------------

Since the *Shaker*-IR-P475A mutant did not affect the early VSD movements, the QV curve was split and displayed two gating charge components whereby the late one corresponded with the voltage dependence of channel gate opening[@b29]. Analyzing the gating currents of *Shaker*-IR-W434F-P475A in presence of 300 mM 1-BuOH or 30 mM 1-HeOH indicated that the voltage dependence of neither the early nor the late gating charge component was affected by 1-BuOH or 1-HeOH ([Fig. 9](#f9){ref-type="fig"} and [Table 1](#t1){ref-type="table"}). This was in agreement with the absence of an obvious shift in the threshold of channel opening ([Fig. 8B](#f8){ref-type="fig"}). Also the I~Gac~ time constants, which in *Shaker*-IR-W434F-P475A report directly on the kinetics of the early VSD movements[@b29], were unaffected by 1-BuOH or 1-HeOH. These I~G~ data confirmed that 1-BuOH and 1-HeOH did not affect the voltage-dependent transitions of the *Shaker*-IR-P475A mutant but facilitated a late largely voltage-independent transition in the activation pathway, a transition that is compromised by the P475A mutation.

Discussion
==========

1-BuOH and 1-HeOH inhibited the *Shaker*--IR channel in a concentration-dependent manner without displaying the classic hallmarks of an open channel blocker. Therefore, alkanols appear to act as gating modifiers that stabilize the channels in a non-conducting state[@b4]. To elucidate which state is stabilized by alkanols, we determined the impact of 1-BuOH and 1-HeOH on the I~G~ recordings of *Shaker*-IR-W434F. Both alkanols caused a concentration-dependent reduction in gating charge movement associated with accelerated VSD deactivation ([Fig. 3](#f3){ref-type="fig"}). This data indicated that alkanols interfere with the transition from the non-conducting activated conformation to full channel gate opening, which occurs in a highly subunit-cooperative (concerted) manner. Consequently, the reduction in either I~K~ or gating charge movement as a function of alkanol concentration yielded concentration-response curves with similar IC~50~ values and Hill coefficients ([Figs 1](#f1){ref-type="fig"},[3](#f3){ref-type="fig"}). Since alkanols have been proposed to operate via the S4-S5 linker[@b18], there are 4 potential alkanol binding sites on the channel that appear to operate largely independently (Hill coefficients of approximately 1). As they interfere with a subunit-cooperative transition, binding of a single alkanol molecule (occupying only one out of four binding sites) can be sufficient to prevent channel gate opening and losing about 10% of the gating charge movement. Accordingly, a previous study, which used concatemeric constructs, showed that channels with less than four high affinity binding sites (e.g. only 2) were still inhibited by alkanols[@b4]. Thus, we propose that alkanols inhibit *Shaker*-IR currents by preventing the channels of passing the final concerted step in the activation sequence that opens the channel gate. Therefore, the ionic current data analysis represented in [figure 2](#f2){ref-type="fig"} reports on the channels that were free of alkanols which explains why both the normalized GV curves ([Fig. 2C](#f2){ref-type="fig"}) and the kinetics ([Fig. 2D](#f2){ref-type="fig"}) in presence of alkanols were similar to control conditions.

The impact of 1-BuOH and 1-HeOH on *Shaker*'s gating charge movement was reminiscent to that of the well-characterized drug 4-AP[@b14], and both compounds stabilize the *Shaker* K~v~ channel in the non-conducting activated state. However, both compounds achieve this by acting via distinct binding sites ([Fig. 6](#f6){ref-type="fig"}). Whereas the binding determinants for 4-AP, including those for guanidine compounds that possibly work in a similar manner[@b30], reside within S6~c~[@b31][@b32], alkanols are suggested to distort the coupling between the S4-S5 linker and S6~c~[@b33]. The observation that alkanols rescued partly the kinetics of the *Shaker*-IR-P475A mutant, favors the idea that alkanols alter the conformation of the S4--S5 linker and/or S6~c~ without disrupting their communication completely. By altering the conformation of the S4-S5 linker and/or S6~c~, the electromechanical coupling is compromised as its operation relies on a correct positioning of both segments with respect to each other[@b34].

Mutations that affect the communication between the VSD and the channel gate might therefore alter the alkanol effect, as is the case in *Shaker*-IR-P475A. Apparently, 1-BuOH and 1-HeOH did not shift the voltage dependence of the late gating charge component in *Shaker*-IR-P475A ([Fig. 9](#f9){ref-type="fig"}), which is expected if the mutation was only to affect the equilibrium constant of the transition from the non-conducting activated to the open state. Therefore, the structural consequences of the P475A mutation should be more severe and the *Shaker*-IR-P475A mutant displayed, accordingly, a biphasic current activation that in absence of alkanols is dominated by the slow component. We propose that alkanol binding to the *Shaker*-IR-P475A channel alters the conformation of the S4-S5 linker and/or its communication with S6~c~ (as it does in WT *Shaker*-IR), and in doing so it coincidentally restores the conformation of the S6~c~ channel gate that is compromised by the mutation. Alkanols then act as activators of the *Shaker*-IR-P475A mutant by yielding I~K~ current activation that is dominated by the fast component ([Fig. 8C--E](#f8){ref-type="fig"}), thus accelerating a late largely voltage-independent transition of channel gate opening. Notably, the effect of both 1-BuOH and 1-HeOH on the *Shaker*-IR-P475A mutant was comparable to the behavior of poly-unsaturated-fatty acids (PUFAs): accelerating channel opening followed by more pronounced channel inactivation at higher concentrations ([Fig. 7A,B](#f7){ref-type="fig"}). PUFAs have been shown to alter the kinetics of K~v~ channels leading to current activation or current inhibition, in part by accelerating the inactivation process[@b35]. At low concentrations several PUFAs act as channel activators but at higher concentrations they result in channel inhibition[@b36][@b37][@b38]. Whereas their activating property is ascribed to their ability to shift the voltage dependence of channel opening towards more hyperpolarized potentials and to facilitate the late subunit-concerted transition of channel opening[@b39][@b40], their molecular mechanism to induce channel inhibition is still debated[@b41]. Whereas alkanols most likely target the S4-S5 linker of K~v~ channels[@b33], PUFAs supposedly exert their effect through the VSD[@b39][@b40], although a role for the S4-S5 linker has been suggested[@b42].

Alkanols and 4-AP immobilize the same VSD movement(s) in the *Shaker*-IR channel ([Fig. 5](#f5){ref-type="fig"}), but both compounds achieve this via distinct drug binding sites ([Fig. 6](#f6){ref-type="fig"}) and a different mechanism of action. This conclusion is further supported by the observation that the mutant *Shaker*-IR-P475A is activated by alkanols ([Figs 7](#f7){ref-type="fig"},[8](#f8){ref-type="fig"}) but is insensitive to 4-AP[@b29]. The presence of other (possibly overlapping) intracellular or lipid-accessible binding sites for gating modifying compounds is supported by: (1) the finding that the gating modifier toxin gambierol occupies a lipid exposed S5-S6 crevice outside the K^+^ pore[@b43], a binding site which is most likely shared by psora compounds[@b44] and (2) the observation that ruthenium complexes uncouple VSD movement from channel gate opening but in contrast to alkanols they immobilize about 50% of the gating charge[@b45]. Furthermore, the binding site for the volatile anesthetic halothane has been shown to overlap with that of alkanols[@b21], and both isoflurane and servoflurane, which belong to the same class of halogenated general anesthetics, potentiate K~v~ channels instead of inhibiting them[@b46][@b47][@b48].

The intoxicating and sedating effects of exposure to high alkanol concentrations are well described and ion channels (including K~v~ channels) do most likely form one of their molecular targets. We provide a mechanistic basis for understanding their effect on K~v~ channels and show that 1-BuOH and 1-HeOH interfere directly with the gating apparatus of the *Shaker*--IR K~v~ channel. They inhibit *Shaker*-IR by stabilizing the non-conducting activated state preventing the channels from passing the final subunit-concerted transition leading to channel gate opening. They achieve this through a unique gating modifying mechanism different from that of 4-AP. Our findings strengthen the idea that there exist different intracellular drug binding sites that via distinct mechanisms of action exert a similar gating modifying effect; this opens new possibilities for designing modulators of K~v~ channels.

Methods
=======

Molecular Biology
-----------------

The N-terminal deletion Δ6--46 *Shaker* clone (*Shaker*-IR), which removes fast inactivation[@b49], was used in this study. The W434F mutation, which yields a non-conducting *Shaker*-IR-W434F channel[@b25], and the P475A mutation were introduced as described previously[@b29]. All channel constructs were expressed using a pGW1 expression vector. The plasmid that codes for the green fluorescent protein, used to identify transfected cells, was purchased from Clontech (Palo Alto, CA, USA). Plasmid DNA for mammalian expression was obtained by amplification in XL2 Bluescript cells (Stratagene), and afterwards isolated using the endotoxin-free Maxiprep kit (Macherey-Nagel, Düren, Germany). The cDNA concentration was determined by UV absorption.

Cell culture
------------

HEK293 cells were cultured in Modified Eagle's Medium (MEM) supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 1% non-essential amino acids (Invitrogen, Carlsbad, CA, USA). Cells were transiently transfected with the appropriate channel DNA plasmids using polyethyleneimine that was purchased from Sigma-Aldrich (St Louis, MO, USA), details of procedure was described previously[@b29].

Electrophysiology
-----------------

Whole-cell ionic I~K~ or gating I~G~ current measurements were done at room temperature (20 to 23 °C) using an Axopatch-200B amplifier and the recordings were digitized with a Digidata-1200 A acquisition system (Molecular Devices, Sunnyvale, CA, USA). Both I~K~ and I~G~ recordings were digitized at 10 kHz sampling rate after passing a 5 KHz Bessel low-pass filter. Command voltages and data storage were controlled with pClamp10 software. Patch pipettes were pulled from 1.2 mm quick-fill borosilicate glass capillaries (World Precision Instruments, Sarasota, FL, USA) with a P-2000 puller (Sutter Instrument Co., Novato, CA, USA) and afterwards heat-polished, to have patch pipettes with a resistance of approximately 1.5 MOhm determined with the filled pipette in the bath solution.

For I~K~ measurements the cells were constantly superfused with external bath solution that contained (in mM) NaCl 130, KCl 4, CaCl~2~ 1.8, MgCl~2~ 1, HEPES 10, Glucose 10, adjusted to pH 7.35 with NaOH. The patch pipettes were filled with internal solution containing (in mM) KCl 110, K~4~BAPTA 5, K~2~ATP 5, MgCl~2~ 1, HEPES 10, adjusted to pH 7.2 with KOH. For I~G~ measurements the monovalent cations were replaced with N-methyl-D-glucamine (NMG^+^). The bath solution contained (in mM) NMG^+^ 140, HEPES 10, Glucose 10, MgCl~2~ 1, CaCl~2~ 1.8, titrated to pH 7.35 with HCl. The pipette solution contained (in mM) NMG^+^ 140, HEPES 10, EGTA 10, MgCl~2~ 1, titrated to pH 7.2 with HCl. Junction potentials were zeroed with the filled pipette in the bath solution and experiments were excluded from analysis if the voltage error estimate exceeded 5 mV after series resistance compensation. For I~G~ measurements, leak currents and remaining capacitive currents were subtracted online using a −P/6 protocol (using a holding potential of −95 mV). I~K~ recordings were not leak corrected.

Drug solutions
--------------

1-BuOH and 1-HeOH (Sigma-Aldrich, St. Louis, MO, US) were directly dissolved in the external recording solution for either I~K~ or I~G~ measurements. The different test concentrations were daily made as both compounds are volatile lowering the effective concentration upon storage. For the highest concentration of 1-BuOH tested (300 mM), the osmolarity of the extracellular solution for I~K~ or I~G~ recordings increased by approximately 300 mOsm resulting in a total osmolarity of \~640 mOsm. Because of the rapid partitioning of alkanols across the plasma membrane, we expected a minor impact of this increase in osmolarity. Indeed, the cells tolerated remarkably well the perfusion of the 300 mM 1-BuOH solution. This was not the case when the cells were perfused with a 600 mOsm extracellular solution that contained glucose, which does not easily partition across the plasma membrane, to increase osmolarity (data not shown). 4-AP was purchased from Sigma-Aldrich and after dissolving it in the external recording solutions the pH was adjusted to 7.35 using HCl. All compounds were applied to the cells using a pressurized fast perfusion system equipped with a quartz micromanifold (ALA scientific, Farmingdale, NY, USA), allowing rapid exchange of the external solutions.

Data analysis
-------------

Details of pulse protocols used to elicit I~K~ or I~G~ recordings were adjusted to determine the biophysical properties of each construct adequately and are shown in the figures or described in legends. All the graphs were built using SigmaPlot 11.0 (Systat Software Inc., San Jose, CA, USA). If not mentioned otherwise, the conductance vs. voltage (GV) curves were determined from analyzing normalized tail current amplitudes and the charge vs. voltage (QV) curves by integrating the activating I~G~ currents. The QV and GV curves of *Shaker*-IR were fitted with a Boltzmann equation: *y* = 1*/*{1 + exp\[−(*V* − *V*~1*/*2~)*/k*\]}, where *V* represents the applied voltage, *V*~1*/*2~ the midpoint potential at which 50% of the total charge has moved or half of the channels have opened, and *k* the slope factor. For the P475A mutant the GV curve was also approximated with a single Boltzmann equation whereas its QV curve was approximated with the sum of two Boltzmann distributions. Activation I~K~ kinetics (τI~Kac~) were determined by approximating the rise in I~Kac~ with a single or double exponential function. Deactivation I~K~ kinetics (τI~Kdeac~) were obtained from single or double exponential fits to the I~Kdeac~ decay elicited at various repolarizing potentials following a 25 ms depolarizing pre-pulse to + 20 mV that activated the channels. When a double exponential function was used to determine the fast (τ~fast~) and slow (τ~slow~) component of the τI~Kac~ and τI~Kdeac~ kinetics, the weighted time constants (τ~W~) were calculated based on the amplitude of each component: τ~W~ = (A~fast~/(A~fast~ + A~slow~)) x τ~fast~ + (A~slow~/(A~fast~ + A~slow~)) x τ~slow~, with A~fast~ and A~slow~ the amplitude of the fast and slow component respectively. The I~G~ activation and deactivation kinetics (τI~Gac~ and τI~Gdeac~) were determined by fitting the decaying part of I~Gac~ and I~Gdeac~ with a single exponential function. All results are expressed as mean ± S.E.M. with *n* the number of cells analyzed.

Concentration--response curves (both from I~K~ and I~G~ analysis) were fitted in the program OriginPro 8 (OriginLab Corp., Northampton, MA, USA) with a Hill equation: I~effect~ = I~min~ + ({I~max~ − I~min~}/{1 + (\[alkanol\]/*IC*~*50*~)^*Hill\ coefficient*^}), where \[alkanol\] is the concentration of 1-BuOH or 1-HeOH and IC~50~ the concentration that induces 50% effect. To test whether 1-BuOH shares a similar and/or overlapping binding site with 4-AP, we performed competition experiments based on a previously described approach[@b28]. The method is based on comparing the experimental determined inhibition to the expected level of channel inhibition using an allotopic (non-competing) or a syntopic model (competing). Formulas used for calculating the expected inhibition in presence of both compounds (*I*~*NX,Y*~) according to the allotopic and syntopic model were *I*~*NX,Y*~* = (I*~*NX*~ *+ I*~*NY*~ − *I*~*NX*~*I*~*NY*~) and I~*N*X,Y~ = ((*I*~*NX*~ *+ I*~*NY*~ − *2I*~*NX*~*I*~*NY*~)/(1− *I*~*NX*~*I*~*NY*~)), respectively. *I*~*NX*~and *I*~*NY*~ were the experimentally determined level of channel inhibition induced by each compound independently. I.e. *I*~*NX*~ was the inhibition induced by 1-BuOH and *I*~*NY*~ the level of inhibition induced by 4-AP. A two way analysis of variance (ANOVA) was used to determine the differences of a dual inhibition. A *post hoc* Dunnett's was used to compare both models.
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![Inhibition of *Shaker*-IR by 1-BuOH and 1-HeOH.\
(**A**) Representative I~K~ recordings of *Shaker*-IR in control condition (left) and in presence of 100 mM 1-BuOH (right) elicited by applying depolarization steps from a -80* *mV holding potential (pulse protocols are shown on top). (**B**) I~K~ recordings of *Shaker*-IR obtained in control conditions (left) and in presence of 3* *mM 1-HeOH (right). (**C**) Steady-state I~K~ recordings (elicited with a voltage step from -80* *mV to 0* *mV) upon wash-in of different concentrations of 1-BuOH (left) and 1-HeOH (right). Establishment of channel inhibition was monitored by repetitive pulsing to 0* *mV. (**D**) Concentration-response curves obtained by plotting the normalized steady-state I~K~ amplitude at 0* *mV, determined from I~K~ recordings as shown in panel C, as a function of 1-BuOH (circles, *n* = 5) or 1-HeOH (triangles, *n* = 7) concentration. Solid lines represent the average fit with a Hill function.](srep17402-f1){#f1}

![Alkanols inhibited I~K~ without affecting the kinetics.\
(**A**) Monitoring the inhibition in I~K~ during application of 50* *mM 1-BuOH (top panel) or 3* *mM 1-HeOH (bottom panel) indicated that the I~K~ inhibition developed rapidly with a time constant of 5.2 ± 1.2 s (*n* = 8) and 3.7 ± 0.7 s (*n* = 9) for 1-BuOH and 1-HeOH respectively. The I~K~ inhibition was fully reversible upon wash-out of both alkanols and the current recovery was relatively fast yielding time constants of 7.6 ± 2.1 s (*n* = 8) and 4.8 ± 1.7 s (*n* = 9) for 1-BuOH and 1-HeOH respectively. (**B**) Normalized peak current versus voltage relationships, obtained from pulse protocols shown in [Fig. 1A](#f1){ref-type="fig"}, in control conditions (open symbols) and presence of 50* *mM 1-BuOH (top panel, *n* = 5) or 3* *mM 1-HeOH (bottom panel, *n* = 6). (**C**) Normalized conduction versus voltage GV curves in control conditions (open symbols) and presence of 50* *mM 1-BuOH (top panel, *n* = 5) or 3* *mM 1-HeOH (bottom panel, *n* = 6). Solid lines represent the average fit with a Boltzmann equation (V~1/2~ and slope factor values are provided in [Table 1](#t1){ref-type="table"}). (**D**) Time constants of I~K~ activation (τI~Kac~) and deactivation (τI~Kdeac~) in control conditions (open symbols) and in presence of 50* *mM 1-BuOH (top panel, *n* = 7) or 3* *mM 1-HeOH (bottom panel, *n* = 8).](srep17402-f2){#f2}

![Impact of alkanols on I~G~ recordings of *Shaker*-IR-W434F.\
(**A**) Representative I~G~ recordings of *Shaker*-IR-W434F recorded in control conditions with the pulse protocol shown on top. Note that prolonging the depolarization at +20* *mV gradually slowed down I~Gdeac~ upon repolarization to −120* *mV. (**B**) Superposition of *Shaker*-IR-W434F steady-state I~G~ recordings in control condition (gray) and in presence of 100 mM (dark gray) and 300* *mM (black) 1-BuOH. Inset shows a scale up view of I~Gac~. Note the gradual acceleration in I~Gdeac~ upon application of higher concentrations of 1-BuOH. (**C**) Superposition of steady-state I~G~ recordings in control condition (gray) and in presence of 3* *mM (dark gray) and 30* *mM (black) 1-HeOH. (**D**) Concentration-response curves obtained by plotting the weighted τI~Gdeac~ at −90* *mV (obtained from I~Gdeac~ recordings shown in panel A and B) as a function of 1-BuOH (circles, *n* = 10) or 1-HeOH (triangles, *n* = 6) concentration. (**E**) Concentration-response curves obtained by plotting the normalized charge movement, which was determined by integrating the steady-state I~Gac~ recordings and normalizing the calculated charge to the total charge moved in control condition, as a function of alkanol concentration.](srep17402-f3){#f3}

![Biophysical properties of *Shaker*-IR-W434F upon alkanol application.\
(**A**) Representative I~Gac~ recordings of *Shaker*-IR-W434F in control condition (left) and in presence of 300* *mM 1-BuOH (right) elicited using the pulse protocols shown on top. (**B**) Representative I~Gdeac~ recordings elicited with the deactivation pulse protocols shown on top; in control conditions (left) and in presence of 100 mM 1-BuOH (right). Inter-sweep holding potential was −90* *mV and the depolarizing pre- and post-pulse to 0* *mV were 15* *ms in duration. (**C**) Charge vs. voltage QV curves in control condition (white circles, *n* = 10) and in presence of 300* *mM 1-BuOH (black circles, *n* = 5) or 30* *mM 1-HeOH (black triangles, *n* = 4) were created by plotting the normalized charge (obtained from integrating I~Gac~ recordings from pulse protocols shown in panel A) as a function of voltage. Curves shown are the average fit to a Boltzmann equation. (**D**) Time constants of VSD activation (τI~Gac~) in control condition (white diamonds, *n* = 8) and in presence of 100* *mM (gray diamonds, *n* = 3) or 300* *mM (black diamonds, *n* = 5) 1-BuOH. For VSD deactivation the weighted τI~Gdeac~ kinetics are shown. Note the gradual acceleration in τI~Gdeac~ between control (white circles), 100* *mM 1-BuOH (gray circles) and 300* *mM 1-BuOH (black circles). (**E**) Panel shows the voltage-dependent τI~Gac~ kinetics in control condition (white squares, *n* = 7) and in presence of 10* *mM (gray squares, *n* = 3) or 30* *mM (black squares, *n* = 4) 1-HeOH. Similar to 1-BuOH the τI~Gdeac~ kinetics accelerated in presence of 10* *mM (gray triangles, *n* = 3) and 30* *mM 1-HeOH (black triangles, *n* = 4), control conditions (white triangles).](srep17402-f4){#f4}

![1-BuOH and 4-AP immobilize the same gating charge component.\
(**A**) Superposition of steady-state I~Gdeac~ recordings of *Shaker*-IR-W434F, elicited during a repolarizing step to -120* *mV upon a 50* *ms depolarization at 0* *mV, in control condition (light gray), in presence of 1* *mM 4-AP (dark gray), and in presence of 1* *mM 4-AP plus 300* *mM 1-BuOH (black). Note that the mixture of 4-AP plus 1-BuOH did not result in an extra acceleration of I~Gdeac~ decay or an extra reduction in gating charge movement. (**B**) Panel shows τI~Gac~ and τI~Gdeac~ in control condition (white circles, *n* = 6), in presence of 4-AP (dark gray squares, *n* = 5), and 4-AP plus 1-BuOH mixture (black circles, *n* = 6). Both drug conditions resulted in a similar acceleration of τI~Gdeac~ without affecting τI~Gac~ markedly.](srep17402-f5){#f5}

![1-BuOH and 4-AP do not compete for inhibiting *Shaker*-IR.\
(**A**) Sequentially recorded I~K~ of *Shaker*-IR in control condition and after steady-state inhibition by 50* *mM 1-BuOH and 30 μM 4-AP. Finally, instead of washing the 30 μM 4-AP out, a mixture of 30 μM 4-AP plus 50* *mM 1-BuOH was added and the amount of I~K~ inhibition was determined. (**B**) Bar chart shows the average reduction in I~K~ ± S.E.M. (*n* = 7) after applying 50* *mM 1-BuOH, 30 μM 4-AP and the mixture of both compounds (30 μM 4-AP plus 50* *mM 1-BuOH). The percentage of I~K~ inhibition was calculated by normalizing the steady-state I~K~ in presence of drug to the I~K~ amplitude in control conditions. The expected reduction in I~K~ for an allotopic and syntopic model was calculated as described in Material and Methods. Note, the experimentally obtained value differed only statistically from the predicted value of a syntopic model (\*p \< 0.05).](srep17402-f6){#f6}

![Alkanol-dependent activation of *Shaker*-IR-P475A.\
(**A**) Steady-state I~K~ recordings of *Shaker*-IR-P475A in control condition (black), 100* *mM (blue), and 300* *mM (red) 1-BuOH elicited using the pulse protocol shown on top. (**B**) Steady-state I~K~ recordings obtained in control condition (black), 10* *mM (blue) and 30* *mM 1-HeOH (red). In presence of alkanols the currents activated markedly faster and current inactivation was more pronounced. Insets show scale up views of the deactivating (I~Kdeac~) tail currents.](srep17402-f7){#f7}

![Biophysical properties of *Shaker*-IR-P475A upon alkanol application.\
(**A**) Representative I~Kac~ recordings of *Shaker*-IR-P475A in control conditions, 100* *mM 1-BuOH and 10* *mM 1-HeOH, elicited using the pulse protocol shown on top. (**B**) Conduction vs. voltage GV curves of *Shaker*-IR-P475A in control conditions (white circles), 100* *mM 1-BuOH (blue circles), 300* *mM 1-BuOH (red cricles), 10* *mM 1-HeOH (blue triangles), and 30* *mM 1-HeOH (red triangles). GV curves displayed in the left panel were obtained by normalizing tail current amplitudes. Solid lines represent the average fit with a Boltzmann equation (V~1/2~ and slope factor values are provided in [Table 1](#t1){ref-type="table"}). Right panel displays the GV curves determined from analyzing the peak outward currents. (**C**) Panels from left to right show the τI~Kac~ values of *Shaker*-IR-P475A upon increasing 1-BuOH concentrations with the left most panel showing the values in control conditions. The fast and slow τI~Kac~ components are represented with open symbols and the weighted τI~Kac~ with filled symbols. Note that the contribution of the fast τI~Kac~ component increased upon higher 1-BuOH concentrations; compare weighted τI~Kac~ values in 30* *mM (yellow symbols) and 100* *mM (blue symbols). In presence of 300* *mM 1-BuOH (red symbols) only the fast component could be resolved and I~Kac~ was approximated with a single exponential function. (**D**) Plot shows the weighted τI~Kac~ and τI~Kdeac~ values in control conditions (white) and in presence of 10* *mM (gray, *n* = 4), 30* *mM (yellow, *n* = 5), 100* *mM (blue, *n* = 8), and 300* *mM (red, *n* = 4) 1-BuOH. (**E**) Plot shows the effect of 1* *mM (gray, *n* = 7), 3 mM (yellow, *n* = 9), 10* *mM (blue, *n* = 5), and 30* *mM (red, *n* = 5) 1-HeOH on the weighted τI~Kac~ and τI~Kdeac~ kinetics. (**F**) Concentration-response curves obtained by plotting the weighted τI~Kac~ at +100* *mV as a function of 1-BuOH (black circles, *n* = 10) and 1-HeOH (gray triangles, *n* = 6) concentration. Solid lines represent the fit with a Hill equation.](srep17402-f8){#f8}

![Alkanols did not affect the I~G~ behavior of *Shaker*-IR-W434F-P475A.\
(**A**) Representative I~G~ recordings of *Shaker*-IR-W434F-P475A recorded in control condition (left recordings) and after approximately 10 minutes wash-in of 300* *mM 1-BuOH (right recordings), elicited with the pulse protocols shown on top. Insets show scale up views of I~Gac~ and I~Gdeac~ respectively. (**B**) Representative I~G~ recordings of *Shaker*-IR-W434F-P475A in presence of 30* *mM 1-HeOH. (**C**) QV curves of *Shaker*-IR-W434F-P475A in control conditions (white circles) and presence of 300* *mM 1-BuOH (black circles, *n* = 5) or 30* *mM 1-HeOH (gray triangles, *n* = 4). (**D**) τI~Gac~ (gray circles) and τI~Gdeac~ (black circles) kinetics of *Shaker*-IR-W434F-P475A in presence of 300* *mM 1-BuOH, which were similar to the kinetics in control condition (white circles). (**E**) Similar to 1-BuOH, 30* *mM 1-HeOH did not affect the τI~Gac~ (gray triangles) or the τI~Gdeac~ (black triangles) kinetics compared to control condition (white triangles).](srep17402-f9){#f9}

###### Midpoint (V~1/2~) and slope factor (*k*) values of the GV and QV curves of *Shaker*-IR, *Shaker*-IR-P475, and their non-conducting W434F variants.

                               GV curve *(voltage dependence of gate opening)*                                                                  
  ------------------------- ----------------------------------------------------- ----------------- ------------------------- ----------------- ---------
         *Shaker*-IR                       **V**~**1/2**~ **(mV)**                 ***k*****(mV)**                                               ***n***
     control conditions                          −27.0 ± 1.3                          5.6 ± 0.7                                                    11
      1-BuOH (50* *mM)                           −28.5 ± 2.3                          5.1 ± 0.7                                                     5
        1-HeOH (3 mM)                            −25.4 ± 1.2                          7.5 ± 0.9                                                     6
      *Shaker*-IR-P475A                    **V**~**1/2**~ **(mV)**                 ***k*****(mV)**                                               ***n***
     control conditions                            74 ± 1                            12.3 ± 0.7                                                     8
      1-BuOH (300* *mM)                            50 ± 1                             6.8 ± 0.7                                                     4
          100* *mM                                 62 ± 1                             9.6 ± 0.4                                                     8
      1-HeOH (30* *mM)                             49 ± 1                             6.6 ± 0.6                                                     5
           10* *mM                                 64 ± 1                            10.7 ± 0.6                                                     5
                                                                                                                                                     
                             **QV curve** *(voltage dependence of VSD movement)*                                                                
      *Shaker*-IR-W434F                    **V**~**1/2**~ **(mV)**                 ***k*****(mV)**                                               ***n***
     control conditions                          −33.2 ± 5.4                         −11.6 ± 2.0                                                   10
      1-BuOH (300* *mM)                          −32.4 ± 3.4                         −12.5 ± 1.7                                                    5
       1-HeOH (30 mM)                            −31.4 ± 0.9                         −10.1 ± 0.8                                                    4
                                                                                                                                                     
                                               ***1st comp***                      ***2nd comp***                                               
   *Shaker*-IR-W434F-P475A                 **V**~**1/2**~ **(mV)**                 ***k*****(mV)**   **V**~**1/2**~ **(mV)**   ***k*****(mV)**   ***n***
     control conditions                          −33.1 ± 0.8                         14.5 ± 0.8            59.6 ± 2.7            10.1 ± 2.4         8
       1-BuOH (300 mM)                           −39.2 ± 1.4                         16.2 ± 1.2            52.2 ± 1.2             9.1 ± 1.1         5
       1-HeOH (30 mM)                            −35.3 ± 1.5                         16.9 ± 1.5            50.2 ± 1.1             3.6 ± 1.4         4
                                                                                                                                                     

[^1]: Present address: Discovery Sciences, Janssen Research and Development, Beerse, 2340, Belgium.
